Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (40)
  • Allergen immunotherapy (76)
  • AllergoOncology (12)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (194)
  • Allied health and primary care (17)
  • Anaphylaxis (99)
  • Artificial Intelligence (10)
  • Asthma (122)
  • Basic immunology (54)
  • Biologicals (70)
  • Biomarkers (51)
  • Comparative veterinary allergology (1)
  • COVID19 (7)
  • Dermatology (103)
  • Drug allergy (145)
  • ENT (20)
  • Environmental allergy and climate change (29)
  • Eosinophilic esophagitis (20)
  • Epidemiology (60)
  • Epithelial cell biology (8)
  • Food allergy (175)
  • Genomics and proteomics (16)
  • Immune deficiencies and autoimmunity (70)
  • Immunomodulation and nutrition (12)
  • Infections (19)
  • Insect venom hypersensitivities (15)
  • Mastocytosis and mast cells (22)
  • Microbiome (7)
  • Occupational allergy (22)
  • Ocular allergy (5)
  • One Health (12)
  • Pediatrics (118)
  • Prevention (36)
  • Systems medicine (13)
Poster available until
  • Until platform closure (46)
Poster categories
  • e-Thematic Poster Session (93)
  • x Thematic Poster Session (980)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (5)
  • L-TPS17 (13)
  • L-TPS18 (9)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • TPS49 (5)
  • TPS51 (1)
  • TPS52 (12)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (1)
  • TPS57 (11)
  • TPS58 (1)
  • TPS59 (12)
  • TPS60 (9)
  • TPS61 (1)
  • TPS62 (8)
  • TPS63 (10)
  • TPS64 (11)
  • TPS65 (7)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
980 results
Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series

Thumbnail

D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"

Thumbnail

D3.418 - Modulation of Mast Cell Activation by Histamine H3 and H4 Receptor Antagonists

Thumbnail

D3.420 - IL-1β, IL-6, and TNF serum levels in mastocytosis are not correlated with psychometric measures, though they correlate to serum tryptase and recurrent edemas

Thumbnail

D3.422 - Evaluating Elevated Baseline Mast Cell Tryptase: Insights from an Adult Allergy Service

Thumbnail

D3.424 - Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis

Thumbnail

D3.425 - Anaphylactic reaction to carpenter bee

Thumbnail

D3.426 - The Frequency of Previous Large Local Reactions in a Group of 158 Patients with a History of Systemic Reaction after Insect Sting

Thumbnail

D3.427 - Current practices in diagnosis and treatment of Hymenoptera venom allergy (HVA) in Poland

Thumbnail

D3.428 - CAP-Inhibition use to diagnose genuine double sensitization to vespoid venoms: description of a spanish cohort

Thumbnail

D3.432 - Anti-inflammatory properties of IPA on epithelial barrier sites

Thumbnail

D3.433 - Transcriptome kinetics of esophageal epithelial cells in response to interleukin 13

Thumbnail

D3.436 - Advancing Equity in Food Allergy Prevention – Insights and Takeaways from CFAAR’s Summit for Advancing Equity in Food Allergy

Thumbnail

D3.437 - An EAACI Task Force Initiative for Visualizing Historical Pollen and Spore Calendars in Europe

Thumbnail

D3.438 - Advances in Automated Pollen Monitoring in Mediterranean Regions: New Developments from the SYLVA Project in Córdoba (Spain)

Thumbnail

D3.439 - On-demand treatment of hereditary angioedema attacks: Assessing self-treatment, outcomes and barriers to early intervention

Thumbnail

D3.47 - Implementing Penicillin Delabelling in an Inpatient setting

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM